Objective: To investigate the utility of intravoxel incoherent motion-diffusion weighted imaging (IVIM-DWI) derived parameters in hypothalamus for monitoring the effect of Exendin-4 (Ex-4) intervention on the feeding behavior in obese diabetic rats within early feeding. Methods: 21 obese and 19 non-obese rats which were treated with streptozotocin injections were initially divided into an obese diabetes group (OD, n = 10), a non-obese diabetes group (D, n = 8), an obese group (O, n = 9) and a non-obese group (N, n = 9). Then, the rats in the 4 groups received subcutaneous injections of Ex-4, and feeding behavior was examined at 5, 35, 65, 95, and 125 min. The hypothalamic function was evaluated by IVIM-DWI. Finally, the relationship between the hypothalamic function and the amount of food intake was analyzed. Results: In comparison with the N group, the food intake significantly decreased in the O , OD, and D groups in response to Ex-4. Furthermore, a significant positive correlation was found between food intake and D values at different times from 5 to 125 min after Ex-4 intervention in all 4 groups. Conclusion: A direct correlation between the change of hypothalamic function and feeding behavior was detected in OD rats with Ex-4 intervention in the early feeding period. The hypothalamic D value derived from IVIM-DWI is promising to reflect the dynamic change of hypothalamic function due to intervention.
Introduction
method to study various responses of hypothalamus to food or appetite related peptide. David et al. [18] had found reduced BOLD signal intensity in hypothalamus when comparing intragastric mixed-nutrient infusion with protein infusion in rats. Furthermore, Malik et al. [19] administered ghrelin intravenously to healthy volunteers after they had a meal and observed the activation of the hypothalamic area controlling appetite.
Manganese-enhanced magnetic resonance imaging (MEMRI) is another useful tool in this field. Chaudhri et al. [20] firstly utilized MEMRI in the study on mice and showed that GLP-1 could reduce the signal of the PVN and increase that the VMH. Although the contrast in MEMRI is more directly related to neural activity and could especially be applied to small brain areas such as the hypothalamus, this approach still requires some special methods to open BBB to accumulate Manganese. Importantly, potentially toxic Mn 2+ doses limit the use in the clinic [21] . Diffusion-weighted imaging MRI (DWI), is a noninvasive tool to investigate the function of the CNS by mapping neuronal activities. It can detect the transition of water diffusion preceding the vascular response and reflect early biophysical events such as cell swelling and membrane expansion of activated cells [22] . To separate signals from larger vessels and minimize the noise from capillaries, intravoxel incoherent motion (IVIM) derived parameters with bi-exponential analysis of multiple b-value DWI were proposed [23] . Lizarbe et al. [24] firstly named this technology functional DWI (fDWI) and successfully detected the change of hypothalamic signal from fasting to feeding in mice by using this technique, which could improve the spatial and temporal resolution detected with BOLD. It is worth mentioning that no drug intervention studies focused on the change of hypothalamus function by using IVIM-DWI method until now.
To our knowledge, IVIM-DWI has not been used thus far to investigate the change of hypothalamic functions in response to drug interventions. Using IVIM-DWI, we aimed to figure out whether there is a potential correlation between food intake and hypothalamus function under Ex-4 administration in obese diabetic rodents.
Material and Methods
Animals 50 6-week, specific pathogen-free (SPF), male Sprague-Dawley rats weighing 140 ± 10 g were purchased from the Animal Experimental Center, Guangdong Academy of Medical Sciences. All rats were housed 4 per cage in a room with an alternating 12-hour dark and light cycle and an ambient temperature of 18-22 ° C. Ten rats were fed with a chow diet (12% fat, 67% carbohydrate, and 21% protein), the other rats (n = 40) were fed with a high-fat diet (40% fat, 41% carbohydrate, and 19% protein) for 8 weeks. Some rats in the second group were randomly induced to obese diabetic rats.
There was no consensus in defining obesity in rodents. We defined obesity as ≥ 20% weight gain than the average of body weight of chow diet group, as described previously [25, 26] . 21 obese and 19 non-obese rats were successfully cultivated and then divided into an obese group (O) and non-obese group (N). These groups were further divided by randomly inducing diabetes via STZ (Sigma Chemical Co. St Louis, MO, USA) to obtain obese diabetes (OD) and non-obese diabetes (D) rats ( fig. 1 ). Rats were fasted for 12 h prior to STZ injection. Freshly prepared 1% STZ (0.1 mmol/l citrate buffer, pH 4.2) was injected intraperitoneally in a single dose (35 mg/kg body weight). After 72 h, rats with plasma glucose level exceeding 16.6 mmol/l were considered as diabetic. Animals that did not meet this criterion were excluded from the study. A total of 11 OD and 9 D rats were successfully modeled; 2 rats failed. All procedures were approved by the Guangzhou Medical University of Medicine Animal Care Committee (Guangzhou, China). All experiments were performed in accordance with relevant guidelines and regulations.
Plasma Analysis
Blood samples were collected from orbital venous plexus under fasting condition. Serum was obtained by centrifugation at 1,400 × g for 10 min, and blood glucose, triglyceride (TG), cholesterol (TC), and insulin were measured according to the kit manual (BHKT Co., Beijing, China).
Feeding
The rats were housed individually with food deprivation but no water deprivation for 24 h. The rats were returned to their cages immediately after subcutaneous injection of 2.5 μg/kgEx-4 (Sigma Chemical Co. St Louis, MO, USA) at 6: 00 pm, and a small can containing some standard food particles weighing 50 g was placed in the cage. The remaining food particles were weighed at 5, 35, 65, 95, and 125 min from the beginning of the test. The test was repeated with vehicle injection at corresponding time points to measure the basic food intake of different rats. Ex-4 can reduce the levels of orexigenic peptide such as ghrelin by nearly up to 25% in fasting rats, leading to a significant reduction of food intake in our preliminary experiment, which prompted us to choose 5 min as an observation time [27] .
Gastrostomy Surgery to Mimic Food Intake
Each rat from 4 groups was undergone a feeding gastrostomy for MRI scanning. A 1.0 mm silicon rubber gastrostomy tube was placed through the greater curvature of the stomach and then tunneled subcutaneously through the midscapular region [28] . Within postoperative 5 days, rats received enteral nutrition (Fresubin HP energy, Fresenius-Kabi, Bad Homburg, Germany) containing 1.5 kcal/ml energy, with 20% from protein, 45% from carbohydrates, and 35% from fat through the gastrostomy catheter by the continuous infusion pump. All rats were not allowed to obtain solid food but were free to drink water. One rat from the OD group and another from the D group died of infections.
MRI Scans
MRI scans were performed on a Philips Achieva 3.0T TX MR. High-fat feedstuff was grounded into a fine granular mixing with distilled water to prepare high-fat forage mixed suspension. After being anesthetized with chloralhydrate just before imaging, rats were scanned with an animal coil (Chenguang Medical Technologies Co., Shanghai, China). In the baseline scan, animals were injected subcutaneously with a dose of 2.5 μg/kg Ex-4 in inner the thigh followed by a mixed suspension of 3 ml high-fat forage through the enteral nutrient canal. MRI scans were repeated at 5, 35, 65, 95, and 125 min. Image Analysis MR images were exported to MATLAB software (The Mathworks Inc., Natik, MA, USA) for analyses. Regions of interest (ROIs) were manually delineated by two experienced radiologists. ROIs were defined 
Statistical Analyses
Statistical analyses were performed with SPSS (version 19.0; IBM Corporation, Armonk, NY, USA). Values are presented as mean ± standard deviation. Weight, TG, TC, fasting blood glucose (FBG), postprandial blood glucose (PBG), insulin, and the basic hypothalamic parameters of the four groups were evaluated by one-way ANOVA test. Food intake and the hypothalamic parameters of the groups after administration of Ex-4 were estimated by repeated measures of ANOVA test. Duncan multiple-range test was employed for post-hoc testing.
Correlation coefficients were obtained by Pearson's linear correlation test or Spearman rank-order test between food intake and the hypothalamic parameters according to normality examination with the ShapiroWilk test. P < 0.05 was considered as statistically significant.
Results

Body Weight, TG, FBG and PBG among the Different Metabolic Rat Groups
Based on body weight, rats were divided into an obese and a non-obese group. For each group, rats were randomly selected and induced into diabetes by STZ. As shown in table 1 , weight of rats among the OD and O group were significantly higher than those among the nonobese group (around 23% heavier). TG of the OD and D groups were higher than those of the N group. However, there were no significant differences for TC among these groups. Both FBG and PBG among the OD and D groups are higher than that among the N group. Fasting insulin does not show any differences among these groups.
Effect of Ex-4 on Food Intake
After Ex-4 treatment, food intake of the 4 group rats were measured at different times. As shown in figure 2 A-D, Ex-4 could significantly reduce food intake of OD, D, and N groups compared to vehicle administration (F OD = 10.545, P OD = 0.031; Fo = 3.729, Po = 0.126; F D = 9.429, P D = 0.032; F N = 55.639, P N = 0.002). As shown in figure 2 E, there was a significant difference between four metabolic rats with regard to food intake (F = 19.383, p = 0.001). fig. 3 A, table 2 ) . The hypothalamic D value of OD is significantly lower than those of the D and O groups (both p < 0.05) but is not different from that of the N group (p > 0.05). The D * and f values shown in figure 3 B,C were not statistically different among the four groups (p > 0.05). As shown in figure 2 , it seems that the hypothalamic D value may be a more sensitive parameter to characterize the feeding behavior. ( fig. 4 A) . The OD group even had a lower hypothalamic D value than the D group that did not show assessment of food intake. The O group had a higher hypothalamic D value than the N group (p < 0.05). Moreover, the diagram tendency of hypothalamic D value is almost consistent with that of food intake. Consistent with figure 3 , the hypothalamic D * and f values failed to show significant difference among groups and fitted with the trend of feeding behavior (p > 0.05) ( fig. 4 B, C) .
Effects of Ex-4 on Hypothalamic Parameters of the Four Groups at Different Times
Effects of Ex-4 on Hypothalamic D Value for Each Group
Ex-4 significantly reduced hypothalamic D value in the OD group from 65 to 95 min, in the O group during 65-95 min, in the D group at 95 min, and in the N group after 35 min (p < 0.05) ( fig. 5 , table 2 ) .
Correlations between Changes of Food Intake and IVIM-Derived Measures after Ex-4 Administration
Significant positive correlations between changes of food intake and hypothalamic D value after Ex-4 intervention were shown in figure 6 . A significant positive correlation was observed between the food intake and hypothalamic D value: OD group, r = 0.633, p = 0.00; O group, r = 0.367, p = 0.02; D group, r = 0.603, p = 0.001; N group, r = 0.342, p = 0.022. The hypothalamic D * and f values showed no correlation with food intake at different times ( fig. 7 ) . The hypothalamic D value might be a good indicator to evaluate the feeding behavior model. 
Discussion
Our study shows that the IVIM-DWI-derived parameters, especially D values, can be used to identify changes of hypothalamic function after Ex-4 intervention in rodents with different metabolic properties. DWI is a non-invasive method measuring random migration of water in the tissues, which has widely been used in clinical practice to detect acute cerebral ischemia (within half an hour). Our previous study [29] showed that DWI allows for objective and accurate measures of kidney function which might be helpful to for identifying diabetic nephropathy at early disease stages. IVIM-DWI technology has been applied in the diagnosis of many diseases, e.g. carcinomas, lesions or infections, but so far its application in hypothalamic feeding studies was only rarely reported [30] [31] [32] . This might be due to the tiny volume of hypothalamus the low magnetic field of which might be easily distorted. The first study using IVIM-DWI to study hypothalamic feeding was done by Lizarbe et al. [24] and revealed a significant increase of hypothalamic signal of mice in the fasting status. In agreement with the study by Lizarbe et al. [24] , we also detected significant differences of the hypothalamus signal between four different metabolic groups of rats after Ex-4 intervention. In addition, both studies used 11 b values including 5 low b values(<100 s/mm 2 ) to sufficiently evaluate the microvascular contribution power in order to correctly discriminate the signal change among rats.
The main advantage of IVIM-DWI is that it is capable to separate the pure molecular diffusion D from the tissue perfusion intervention. For example, the D value is able to differentiate benign from malignant tissues, especially high-grade carcinomas from low-grade ones in prostate cancer or liver cell cancer [33, 34] . Besides, the D * value has been found to be significantly reduced in cirrhotic liver patients due to the decreased perfusion caused by liver fibrosis [35, 36] . It was suggested that IVIM parameters are feasible to reflect the histopathologic features of different organs. In the present study, the hypothalamic D value was proven to show a good fit with food intake, suggesting that it could be applied to study hypothalamic feeding-related function. However, the perfusion-relevant parameters (f and D * value) failed to reflect the food intake behavior, suggesting that changes of hypothalamic microcirculation do not play a significant role in the control of appetite. The D value, referring to the real diffusion index may reflect the volume change of astrocytes due to the osmotic swelling stimulated by feeding-related neurons [24] . Recently, Lizarbe et al. [37] investigated mice genetically deficient in leptin or NPY pathways in the hypothalamus using fDWI with 7T MRI. They not only observed significantly larger increases in the diffusion parameters SDP and D slow in leptin-deficient mice when compared to controls, but also could not show any variations of the SDP and D slow parameters in NPY-deficient mice, suggesting that fDWI is an adequate measure to investigate in vivo hypothalamic pathways of appetite disorders.
At baseline, OD rats have a lower hypothalamic D value than other rats indicating that OD rats had a relatively lower hunger signal compared to other groups. Wellman et al. [38] used BOLD-fMRI to investigate the relationship between ghrelin (a sole orexigenic gut hormone secreted by the stomach that induced increasing food intake) and rats' behaviors and observed a stimulated signal after ghrelin administration . Moreover, Goldstone et al. [39] demonstrated that there is similar hypothalamic performance when comparing ghrelin administration after feeding and fasting status in normal subjects. These studies suggested that ghrelin has a key role in starting feeding behavior as the level of plasma ghrelin increased before feeding and decreased after feeding. The lower hypothalamic D values of OD rats might thus be explained by reduced plasma ghrelin as a result of obesity and diabetes [40, 41] . Notably, it can be further speculated that the coexistence of obesity and type 2 diabetes may further influence the release of the hypothalamus feeding center signal.
After Ex-4 intervention, the sequential sensitivity of the hypothalamus to Ex-4 intervention in our study follows the pattern O< OD ≈ D < N. Haiko et al. [42] found that even among people with obesity, there are different hypothalamic responses to Ex-4. By using resting-state fMRI they observed that Ex-4 responders showed significantly higher involvement of the hypothalamus than non-responders. This finding indicates that the hypothalamic response on GLP-1 could play a crucial role in food intake. In addition, Masafumi et al. [43] found that the hypothalamic inhibitory response after oral glucose ingestion was markedly attenuated and delayed in patients with obesity when compared with non-obese ones. Solrun et al. [44] demonstrated that glucose ingestion failed to decrease the hypothalamic feeding signal in obese diabetic patients. They concluded that the abnormal metabolic state of these subjects contributed to the improper response of the hypothalamus to triggers such as nutrition and many gut peptides, which may hamper the postprandial feeling of satiety in obese diabetic patients. The above mentioned studies suggested that obesityrelated factors may inhibit the response of hypothalamus to glucose intake. In the present study, the feeding inhibition demonstrated in the OD and O groups when compared to the N group may be related to the obesity-related factor influencing the response of the hypothalamus to Ex-4. In addition, the effects on feeding behavior in the OD, D and O groups in response to changes of the hypothalamic D value were found to be delayed when compared with the N group. For example, the food intake in the OD group decreased at 125 min, whereas IVIM-DWI showed that the obvious inhibition of the hypothalamic D value was at 65 and 95 min. One reason may be that patients with obesity had an abnormal high level of ghrelin which was maintained over longer time after meals so that no significant decreased food intake was observed from 0 to 95 min [45, 46] and the food intake between meals was increased. In rodents, the inhibition signal ahead of feeding behavior may trigger a dynamic process of continuously decreasing subjective hunger and enhanced the effect of the drug.
We found a consistent correlation between food intake and the hypothalamic D value for each metabolic group after Ex-4 administration. It is supposed that intubated feeding, which bypasses oropharyngeal and esophageal exposure leading to longer gastric emptying time and reduced insulinemic responses (IR), may have more pronounced effects on appetiteregulating enzymes than oral feeding. But no significant differences between the two conditions were detected with regard to insulin, GLP-1 or ghrelin as well as with regard to satiety ratings or even food intake [47] [48] [49] . One could argue that the mixed suspension of feeding powder would have shorter time course of nutrition absorption which may influence the bioavailability of nutrition. A previous study has shown that ingestion in solid form has the same bioequivalence as the suspension or other solution form, which may imply that the delivered form of food might not always significantly influence the process of absorption related to appetite control [50] .
Our study is hampered by several limitations. First, hormones such as ghrelin and leptin in the plasma were not measured. Thus it was not objectively and directly demonstrated that these obesity-related factors had an impact on hypothalamic signal and feeding behavior. Secondly, the effect of anesthetization on the hypothalamic IVIM-DWI parameters was not known. Thirdly, the coexistence of obesity and type 2 diabetes may further influence the release of the parameters in the hypothalamus feeding center at baseline. TheEx-4 injections resulted in a significant inhibition of the early feeding behavior of OD rats. Whether or not obesity-related factors such as feeding-related peptides change feeding behavior and hypothalamic function requires further investigations. Finally, a clinical 3T MR scanner is inferior to scan rat brain. However, IVIM-derived parameters can be used to identify different responses to Ex-4 in rodents differing in metabolic status. Imaging with higher than 3T MR or clinical imaging for this purpose will be investigated in the future.
Conclusion
In the present study, a direct correlation between the change of hypothalamic function and feeding behavior was detected in OD rats with Ex-4 intervention in the early feeding period. In addition, our study indicated that the hypothalamic D value derived from IVIM-DWI is a promising tool to measure the dynamic change of hypothalamic function due to intervention.
